Abiomed (ABMD) Guides FY12 Sales Above the Street

May 16, 2012 7:14 AM EDT
Abiomed (Nasdaq: ABMD) sees FY12 sales up 20-24 percent, which would imply sales of $152-$157 million, which compares to the Street estimate of $124.16 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Guidance